Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer
Authors
Keywords
VERU-111, Pancreatic cancer, β –tubulins, miR-200c, βIII/βIV-tubulin inhibitor
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-24
DOI
10.1186/s13046-018-1009-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
- (2018) Sonam Kumari et al. Oncogenesis
- Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer
- (2018) Prashanth Nagesh et al. Cancers
- An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance
- (2017) Amelia L. Parker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression
- (2017) Bilal Bin Hafeez et al. MOLECULAR CANCER THERAPEUTICS
- Pancreatic Cancer Chemoresistance to Gemcitabine
- (2017) Manoj Amrutkar et al. Cancers
- Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
- (2016) Xiaoxin Wu et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids
- (2016) G. Sharbeen et al. NEOPLASIA
- Non-adherent culture induces paclitaxel resistance in H460 lung cancer cells via ERK-mediated up-regulation of βIVa-tubulin
- (2015) Korakot Atjanasuppat et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Ormeloxifene Suppresses Desmoplasia and Enhances Sensitivity of Gemcitabine in Pancreatic Cancer
- (2015) Sheema Khan et al. CANCER RESEARCH
- Taxane anticancer agents: a patent perspective
- (2015) Iwao Ojima et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Update on the management of pancreatic cancer: Surgery is not enough
- (2015) Daniel Ansari et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The role of dynamic instability in microtubule organization
- (2014) Tetsuya Horio et al. Frontiers in Plant Science
- βIII-Tubulin: biomarker of taxane resistance or drug target?
- (2013) Roshan Karki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Evidence for predictive role of BRCA1 and bTUBIII in gastric cancer
- (2013) Vladimir M. Moiseyenko et al. MEDICAL ONCOLOGY
- In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
- (2012) Hiroaki Kiyokawa et al. Anti-Cancer Agents in Medicinal Chemistry
- Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents
- (2012) Jianjun Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Desmoplasia in Pancreatic Cancer. Can We Fight It?
- (2012) E. E. Merika et al. Gastroenterology Research and Practice
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Synthesis and antiproliferative activity of novel 2-aryl-4-benzoyl-imidazole derivatives targeting tubulin polymerization
- (2011) Jianjun Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MUC13 Mucin Augments Pancreatic Tumorigenesis
- (2011) S. C. Chauhan et al. MOLECULAR CANCER THERAPEUTICS
- Initial steps of metastasis: Cell invasion and endothelial transmigration
- (2011) Franziska van Zijl et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Discovery of Novel 2-Aryl-4-benzoyl-imidazoles Targeting the Colchicines Binding Site in Tubulin As Potential Anticancer Agents
- (2010) Jianjun Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- Cell-cycle control in the face of damage – a matter of life or death
- (2009) Paul R. Clarke et al. TRENDS IN CELL BIOLOGY
- Increased Levels of a Unique Post-Translationally Modified βIVb-Tubulin Isotype in Liver Cancer†
- (2008) Leah M. Miller et al. BIOCHEMISTRY
- G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
- (2008) N Bucher et al. BRITISH JOURNAL OF CANCER
- Tubulin-Targeted Drug Action: Functional Significance of Class II and Class IVb -Tubulin in Vinca Alkaloid Sensitivity
- (2008) P. P. Gan et al. CANCER RESEARCH
- Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
- (2008) Pascal Sève et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now